top of page
Search Results

381 items found for "Chris Tate"

Programs (1)

  • Step 1

    Consider adding a questionnaire to ask participants what they hope to take away from the experience,

View All

Posts (170)

  • 📰 GPCR Weekly News, February 13 to 19, 2023

    Get ready to stay up-to-date with the latest research, advancements, and news in the field. From the scientist’s view: a conversation with … Chris Tate AI is dreaming up drugs that no one has ever

  • Dr. GPCR Virtual Cafe with Matthew Eddy - New date!

    ☕ We are excited to announce our rescheduled Dr. GPCR Virtual Cafe session with Dr. Matthew E. on Friday, October 7th at 1 PM ET. Don't miss the chance to listen to his latest research on the field. It's a great opportunity to get warmed up for the upcoming Summit starting the next Monday. Get your ticket today on Eventbrite! ➡

  • A central alarm system that gates multi-sensory innate threat cues to the amygdala

    September 2022 "Perception of threats is essential for survival. Previous findings suggest that parallel pathways independently relay innate threat signals from different sensory modalities to multiple brain areas, such as the midbrain and hypothalamus, for immediate avoidance. Yet little is known about whether and how multi-sensory innate threat cues are integrated and conveyed from each sensory modality to the amygdala, a critical brain area for threat perception and learning. Here, we report that neurons expressing calcitonin gene-related peptide (CGRP) in the parvocellular subparafascicular nucleus in the thalamus and external lateral parabrachial nucleus in the brainstem respond to multi-sensory threat cues from various sensory modalities and relay negative valence to the lateral and central amygdala, respectively. Both CGRP populations and their amygdala projections are required for multi-sensory threat perception and aversive memory formation. The identification of unified innate threat pathways may provide insights into developing therapeutic candidates for innate fear-related disorders." Read more at the source #DrGPCR #GPCR #IndustryNews

View All

Other Pages (210)

  • Ep 32 with Dr. Chris Tate

    Chris Tate About this episode Dr. Chris Tate obtained his Ph.D. from the University of Bristol in 1989 and then moved to the University Chris also worked on the E. coli multidrug transporter EmrE and obtained both 2D and 3D crystals as well Join me to learn more about Chris’s work and his role in founding Heptares which was later acquired by Chris Tate on the web LinkedIn ResearchGate Pubmed Google Scholar Sosei Heptares Wikipedia MRC Laboratory

  • 21-04 Dr GPCR Newsletter

    Chris Tate , and Dr. David Gloriam . metastable cytoplasmic PKA network Latrophilin GPCR signaling mediates synapse formation The ligand-bound state receptor usage and enhances its activity toward neutrophils and monocytes The RanBP2/RanGAP1-SUMO complex gates imaging of GPCR dimers in living cells The Effects of Sodium Ions on Ligand Binding and Conformational States webinar on Chemical probes for GPCRs - from bias signaling and allostery to novel technologies which takes

  • Ep 95 with Chris Langmead

    GPCR Podcast << Back to podcast list Chris Langmead Chris Langmead is Professor, Deputy Director, and in drug discovery, particularly in the field of psychiatry, where he has led multiple projects into late Prior to joining Heptares, Chris was a neuroscience researcher at GlaxoSmithKline, UK (1998-2009). Chris serves on the editorial boards of the British Journal of Pharmacology, ACS Chemical Neuroscience help us understand your needs to bring you exciting and informative content; this short survey should take

View All